Press releases11.06.26 Camallergy launches Cambridge Allergy Partners to expand access to specialist allergy care across the UK04.04.24 MHRA grants Promising Innovative Medicine designation to Camallergy’s peanut allergy treatment29.11.23 Camallergy and OnDosis announce a groundbreaking partnership to revolutionize food allergy treatment30.01.23 Camallergy wins £2m additional funding through second Innovate UK Biomedical Catalyst award01.07.22 FDA accepts Camallergy's phase 3 IND for "CA002" novel treatment for peanut allergy23.03.21 Camallergy awarded £1.1m funding under Innovate UK Biomedical Catalyst Award for novel peanut allergy treatment 08.01.21 Camallergy’s UK-based manufacturing facility receives cGMP licences for peanut allergy treatment07.10.20 Camallergy’s Chief Medical Officer receives distinguished award from British Allergy SocietyNews Subscribe
